All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B Virus Infection-10827158

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	10827158	M552I	P	P	Hepatitis B Virus Infection	D	View
2	10827158	M552V	P	P	Hepatitis B Virus Infection	D	View
3	10827158	L528M	P	P	Hepatitis B Virus Infection	D	View
4	10827158	Y472D	P	P	Hepatitis B Virus Infection	D	View
5	10827158	A529T	P	P	Hepatitis B Virus Infection	D	View
6	10827158	D553V	P	P	Hepatitis B Virus Infection	D	View
7	10827158	L527P	P	P	Hepatitis B Virus Infection	D	View
8	10827158	L528R	P	P	Hepatitis B Virus Infection	D	View
9	10827158	M552Q	P	P	Hepatitis B Virus Infection	D	View
10	10827158	Q530X	P	P	Hepatitis B Virus Infection	D	View
11	10827158	Y551N	P	P	Hepatitis B Virus Infection	D	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.